enVVeno Medical (NVNO) Financials: Revenue & Earnings

NVNO price $7.08 +0.34 +5.04%

Ticker
NVNO
Price
$7.08
Change
+0.34 +5.04%
Market cap ?
$4.92M
P/E ?
-0.01
Dividend yield ?
0.00%
Beta ?
1.07
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
52
Value
60
Quality
46
Growth
50

Stocklytics score rationale: value 60, quality 46, growth 50.

Financials

2016201720182019202020212022202320242025
78591242211118655231243000000

enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized…

Fair value

NVNO fair value Not meaningful. Price $7.08.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare NVNO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-30—-3.27—2.25M
2026-07-30-5.37-4.69—1.00M
2026-05-07-5.89-8.40—500.00K
2026-03-26-227.07-9.80—2.60M
2025-10-29-281.75-10.50—1.40M
2025-07-30-11.55-9.80—400.00K
2025-04-30-7.70-11.90—400.00K
2025-02-28-0.35-0.35—1.00M
2024-10-31-0.35-0.33—600.00K
2024-07-29-0.31-0.36—300.00K
2024-05-08-0.31-0.40—100.00K
2024-03-01-0.36-0.46——
2023-10-26-0.45-0.48——
2023-08-02-0.58-0.49——
2023-05-01-20.00-0.48——
2023-03-02-0.55-0.57——
2022-10-27-0.54-0.52——
2022-08-03-0.63-0.33——
2022-04-29-0.47-0.29——
2022-03-28-32.98-0.33——
2022-01-04-0.26-0.34——
2021-08-10-0.28-0.34——
2021-05-12-0.48-0.34——
2021-03-31-2.46-0.98——
2020-11-17-1.25-1.25——
2020-08-14-2,315.25———
2020-06-08-1,923.25———
2020-03-18-3.25-3.25—30.00K
2019-10-31-2.50-3.50—60.00K
2019-08-05-4,018.00-2.75—120.00K
2019-06-13-39.32-0.0731.24K30.00K
2019-03-13-46.43—30.46K—
2018-11-07-38.34—41.66K—
2018-08-10-323.77—83.36K—
2018-03-31-14,342.86—31.07K—
2017-12-31-9,886.20—175.12K—
2017-09-30-7,135.66—27.88K—
2017-06-30-3,488.58—38.80K—
2017-03-31-3,250.42—180.31K—
2016-12-31-4,302.39—304.86K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-11Duhay FrancisSell11$11.21123
2026-06-11Duhay FrancisSell140$10.301.44K
2026-03-12Duhay FrancisSell140$11.521.61K
2025-12-16BERMAN ROBERT ANDREWSell200.00K——
2025-12-16Alavi HamedSell50.00K——
2025-12-16Glickman Marc H.Sell100.00K——
2025-12-11Duhay FrancisBuy135.88K$0.3344.16K
2025-12-11Gray RobertBuy135.88K$0.3344.16K
2025-12-11Jenusaitis MatthewBuy135.88K$0.3344.16K
2025-12-11Shrivastava SanjayBuy135.88K$0.3344.16K
2025-12-11Duhay FrancisSell4.90K$0.361.74K
2025-09-15Duhay FrancisSell4.90K$0.834.07K
2025-05-19Bright JenniferBuy350.00K$3.621.27M
2025-05-19Bright JenniferOther0——
2024-12-31Duhay FrancisBuy81.43K$3.07250.00K
2024-12-31Gray RobertBuy3.50K$2.9410.29K
2024-12-24Shrivastava SanjayBuy5.40K$2.9015.66K
2024-12-19Jenusaitis MatthewBuy9.62K$2.5324.34K
2024-12-19BERMAN ROBERT ANDREWBuy12.00K$2.5530.60K
2024-12-18BERMAN ROBERT ANDREWBuy200.00K$2.57514.00K
2024-12-18Duhay FrancisBuy19.75K$2.5750.76K
2024-12-18Gray RobertBuy19.75K$2.5750.76K
2024-12-18Alavi HamedBuy75.00K$2.57192.75K
2024-12-18Shrivastava SanjayBuy19.75K$2.5750.76K
2024-12-18Glickman Marc H.Buy75.00K$2.57192.75K
2024-12-18Jenusaitis MatthewBuy19.75K$2.5750.76K
2024-03-13Alavi HamedSell8.33K$3.5929.92K
2024-03-13Alavi HamedBuy8.33K$3.5929.92K
2024-03-13Alavi HamedSell8.33K$6.2251.84K
2023-12-05Glynn CraigBuy75.00K$3.59269.25K
2023-12-05Jenusaitis MatthewBuy13.86K$3.5949.74K
2023-12-05Alavi HamedBuy100.00K$3.59359.00K
2023-12-05Glickman Marc H.Buy100.00K$3.59359.00K
2023-12-05Gray RobertBuy13.86K$3.5949.74K
2023-12-05Shrivastava SanjayBuy13.86K$3.5949.74K
2023-12-05Duhay FrancisBuy13.86K$3.5949.74K
2023-12-05BERMAN ROBERT ANDREWBuy300.00K$3.591.08M
2023-01-18Alavi HamedSell8.00K$10.0080.00K
2023-01-18Alavi HamedSell125.92K$6.70843.70K
2023-01-18Alavi HamedSell320.00K$8.202.62M
2023-01-18Alavi HamedSell50.00K——
2022-11-30Jenusaitis MatthewBuy8.40K——
2022-11-30Shrivastava SanjayBuy8.40K——
2022-11-30Gray RobertBuy8.40K——
2022-11-30Duhay FrancisBuy8.40K——
2022-09-13Gray RobertBuy1.04K——
2022-09-13Gray RobertSell1.04K——
2022-09-13Jenusaitis MatthewBuy1.04K——
2022-09-13Jenusaitis MatthewSell1.04K——
2022-08-16Duhay FrancisBuy7.75K$6.1447.59K
2022-06-30Shrivastava SanjayBuy1.00K$3.853.85K
2022-06-27BERMAN ROBERT ANDREWBuy2.50K$3.809.50K
2021-11-30BERMAN ROBERT ANDREWBuy349.78K$6.702.34M
2021-11-30BERMAN ROBERT ANDREWBuy349.78K——
2021-11-30BERMAN ROBERT ANDREWBuy200.00K——
2021-11-30BERMAN ROBERT ANDREWBuy200.00K——
2021-11-30Glickman Marc H.Buy265.70K$6.701.78M
2021-11-30Glickman Marc H.Buy100.00K——
2021-11-30Glynn CraigBuy125.92K$6.70843.70K
2021-11-30Glynn CraigBuy50.00K——
2021-11-30Gray RobertBuy7.21K$6.7048.31K
2021-11-30Duhay FrancisBuy7.21K$6.7048.31K
2021-11-30Jenusaitis MatthewBuy7.21K$6.7048.31K
2021-11-30Shrivastava SanjayBuy7.21K$6.7048.31K
2021-11-19BERMAN ROBERT ANDREWBuy2.00K$7.4314.86K
2021-11-19BERMAN ROBERT ANDREWBuy2.00K$7.4314.86K
2021-11-16Shrivastava SanjayBuy388——
2021-11-16Shrivastava SanjaySell388——
2021-11-16BERMAN ROBERT ANDREWBuy2.00K$7.8715.74K
2021-11-16BERMAN ROBERT ANDREWBuy2.00K$7.8715.74K
2021-09-13Jenusaitis MatthewBuy1.04K——
2021-09-13Jenusaitis MatthewSell1.04K——
2021-09-13Gray RobertBuy1.04K——
2021-09-13Gray RobertSell1.04K——
2021-08-25Jenusaitis MatthewBuy1.30K$7.7010.01K
2021-06-16Gray RobertBuy2.00K$6.2512.50K
2021-05-21Glickman Marc H.Buy1.60K$5.909.44K
2021-05-18BERMAN ROBERT ANDREWBuy3.00K$5.4716.41K
2021-05-18BERMAN ROBERT ANDREWBuy3.00K$5.4716.41K
2021-05-17Duhay FrancisBuy9.49K$5.3350.59K
2021-02-18Glynn CraigBuy324.00K$8.202.66M
2021-02-18Duhay FrancisBuy5.67K——
2021-02-18Jenusaitis MatthewBuy5.67K$8.2046.52K
2021-02-18Shrivastava SanjayBuy5.67K——
2021-02-18BERMAN ROBERT ANDREWBuy838.00K$8.206.87M
2021-02-18BERMAN ROBERT ANDREWBuy838.00K$8.206.87M
2021-02-18Gray RobertBuy5.67K$8.2046.52K
2021-02-18Glickman Marc H.Buy406.00K$8.203.33M
2020-08-21Biodyne Holding, S.A.Sell75.00K$0.3828.50K
2020-08-20Biodyne Holding, S.A.Sell75.00K$0.2720.25K
2020-08-19Biodyne Holding, S.A.Sell50.00K$0.3015.00K
2020-08-18Biodyne Holding, S.A.Sell50.00K$0.3417.00K
2020-08-14Biodyne Holding, S.A.Sell50.00K$0.3115.50K
2020-08-03Biodyne Holding, S.A.Sell70.00K$0.3222.40K
2020-07-31Biodyne Holding, S.A.Sell5.00K$0.341.70K
2020-07-30Biodyne Holding, S.A.Sell25.00K$0.328.00K
2020-07-21Biodyne Holding, S.A.Sell50.00K$0.4522.50K
2020-07-20Biodyne Holding, S.A.Sell150.00K$0.4364.50K
2020-07-18Glynn CraigBuy4.00K$10.0040.00K
2020-07-18Jenusaitis MatthewBuy100.00K$0.4040.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 17, holders 0 vs prior quarter. Ownership 13.22%.

HolderSharesChangeChange %Value
KINGDON CAPITAL MANAGEMENT, L.L.C.36.17K36.17KNew387.34K
CM MANAGEMENT, LLC35.71K35.71KNew382.50K
VANGUARD CAPITAL MANAGEMENT LLC6.29K00.00%67.40K
JPMORGAN CHASE & CO5.21K5.21KNew59.11K
VANGUARD FIDUCIARY TRUST CO2.18K00.00%23.41K
WESTSIDE INVESTMENT MANAGEMENT, INC.1.52K1.52KNew16.33K
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.539539New5.77K
BLACKROCK, INC.414414New4.43K
TOWER RESEARCH CAPITAL LLC (TRC)331-211-38.93%3.54K
WELLS FARGO & COMPANY/MN114114New1.22K
ALLIED PRIVATE WEALTH LLC8888New978
VANGUARD GLOBAL ADVISERS, LLC7700.00%825
MORGAN STANLEY5959New632
OSAIC HOLDINGS, INC.77New74
BARCLAYS PLC22New21
GROUP ONE TRADING LLC22New21
UBS GROUP AG11New11
GEODE CAPITAL MANAGEMENT, LLC0——0
CITIGROUP INC0-1-100.00%0
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO0-2-100.00%0

Earnings and financials

enVVeno Medical Corporation (NVNO) trades at $7.08, with a market cap of $4.92M and a trailing P/E of -0.01. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
78591242211118655231243000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

enVVeno Medical (NVNO) Financials: Revenue & Earnings

NVNO$7.08+0.34 +5.04%

$4.92M

Market Cap

-0.01

P/E

—

Forward P/E

52

Score

Price History